Literature DB >> 9811921

Pathophysiology of progressive nephropathies.

G Remuzzi1, T Bertani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811921     DOI: 10.1056/NEJM199811123392007

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  208 in total

1.  Interstitial nephritis: another kissing disease?

Authors:  E G Neilson
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Nephrology: 2. Evaluation of asymptomatic hematuria and proteinuria in adult primary care.

Authors:  Andrew A House; Daniel C Cattran
Journal:  CMAJ       Date:  2002-02-05       Impact factor: 8.262

3.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Authors:  J Yang; Y Liu
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 4.  The renaissance of corticotropin therapy in proteinuric nephropathies.

Authors:  Rujun Gong
Journal:  Nat Rev Nephrol       Date:  2011-12-06       Impact factor: 28.314

5.  Transforming growth factor-beta1 is up-regulated by podocytes in response to excess intraglomerular passage of proteins: a central pathway in progressive glomerulosclerosis.

Authors:  Mauro Abbate; Carla Zoja; Marina Morigi; Daniela Rottoli; Stefania Angioletti; Susanna Tomasoni; Cristina Zanchi; Lorena Longaretti; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 6.  Chronic renal disease.

Authors:  Malvinder S Parmar
Journal:  BMJ       Date:  2002-07-13

Review 7.  Compelling drug indications in diabetic and nondiabetic nephropathy.

Authors:  Eberhard Ritz; Ralf Dikow; Martin Zeier
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

Review 8.  Angiotensin II and the glomerulus: focus on diabetic kidney disease.

Authors:  James W Scholey
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

9.  Risk factors for renal failure in children with non-glomerular nephropathies.

Authors:  Mieczysław Litwin
Journal:  Pediatr Nephrol       Date:  2003-12-18       Impact factor: 3.714

10.  Peroxisome proliferator-activated receptor gamma (PPAR-gamma) agonist increases plasma adiponectin levels in type 2 diabetic patients with proteinuria.

Authors:  Mahmut Ilker Yilmaz; Alper Sonmez; Kayser Caglar; Deniz Engin Gok; Tayfun Eyileten; Müjdat Yenicesu; Cengizhan Acikel; Necati Bingol; Selim Kilic; Yusuf Oguz; Abdulgaffar Vural
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.